Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-qs9v7 Total loading time: 0 Render date: 2024-07-13T20:42:44.892Z Has data issue: false hasContentIssue false

Chapter 50 - Autotransplants for Germ Cell Tumor: How Best To Do It

from Section 14 - Autotransplants for Solid Neoplasms

Published online by Cambridge University Press:  24 May 2017

By
Craig Nichols ,
Christian Kollmannsberger  and
Lawrence Einhorn
Edited by
Hillard M. Lazarus ,
Robert Peter Gale ,
Armand Keating ,
Andrea Bacigalupo ,
Reinhold Munker  and
Kerry Atkinson
Edited in association with
Syed Ali Abutalib
Hillard M. Lazarus
Affiliation:
Case Western Reserve University, Ohio
Robert Peter Gale
Affiliation:
Imperial College London
Armand Keating
Affiliation:
University of Toronto
Andrea Bacigalupo
Affiliation:
Ospedale San Martino, Genoa
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Kerry Atkinson
Affiliation:
University of Queensland
Syed Ali Abutalib
Affiliation:
Midwestern Regional Medical Center, Cancer Treatment Centers of America, Chicago
Get access
Type
Chapter
Information
Hematopoietic Cell Transplants
Concepts, Controversies and Future Directions
 , pp. 485 - 490
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Einhorn, LH. Treatment of testicular cancer: a new and improved model. JClin Oncol 8:1777–1781, 1990CrossRefGoogle ScholarPubMed
Nichols, CR, Tricot, G, Williams, SD et al. Dose-intensive chemotherapy in refractory germ cell cancer. A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932–939, 1989CrossRefGoogle ScholarPubMed
Nichols, CR, Anderson, J, Lazarus, HM, et al. High dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group Protocol. J Clin Oncol 10:558–563, 1992CrossRefGoogle ScholarPubMed
Lorch, A, Kollmannsberger, C, Hartmann, JT, et al. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group. J Clin Oncol 25:2778–84, 2007CrossRefGoogle ScholarPubMed
Einhorn, LH, Williams, SD, Chamness, A, et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 357:340–8, 2007CrossRefGoogle ScholarPubMed
Lorch, A, Beyer, J, Bascoul-Mollevi, C, et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 28:4906–11, 2010Google ScholarPubMed
Pico, JL, Rosti, G, Kramar, A, et al. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16:1152–9, 2005CrossRefGoogle ScholarPubMed
Lorch, A, Kleinhans, A, Kramar, A, et al. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. J Clin Oncol 30:800–5, 2012CrossRefGoogle ScholarPubMed
Lorch, A, Bascoul-Mollevi, C, Kramar, A, et al. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. J Clin Oncol 29:2178–84, 2011CrossRefGoogle ScholarPubMed
Albers, P, Ganz, A, Hannig, E, et al. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 164:381–4, 2000CrossRefGoogle ScholarPubMed
Coogan, CL, Foster, RS, Rowland, RG, et al. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone. Urology 50:957–62, 1997CrossRefGoogle ScholarPubMed
Beck, SD, Foster, RS, Bihrle, R, et al. Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer. Urol Oncol 23:423–30, 2005CrossRefGoogle ScholarPubMed
Olofsson, SE, Tandstad, T, Jerkeman, M, et al. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group J Clin Oncol 29:2032–9, 2011CrossRefGoogle ScholarPubMed
Adra, N, Albany, C, Sonnenburg, D, Tong, Y, Hanna, NH, Einhorn, LH. A retrospective analysis of patients with poor-risk germ cell tumor (PRGCT) treated at Indiana University from 2000 to 2010. J Clin Oncol 31:Suppl; abstr 4557, 2013CrossRefGoogle Scholar
Chevreau, C, Droz, JP, Pico, JL et al. Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non- seminomatous germ cell tumours. Preliminary results of a French randomized trial. Eur Urol 23:213–7, 1993Google ScholarPubMed
Droz, JP, Kramar, A, Biron, P et al. Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-Volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial. Eur Urol 51:739–46, 2007CrossRefGoogle ScholarPubMed
Motzer, RJ, Mazumdar, M, Gulati, SC et al. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Natl Cancer Inst 85:1828–35, 1993CrossRefGoogle ScholarPubMed
Bokemeyer, C, Kollmannsberger, C, Meisner, C et al. First-line high-dose chemotherapy compared to standard- dose PEB/VIP chemotherapy in patients with advanced germ cell tumors. A multivariate and matched pair analysis. J Clin Oncol; 17:3450–6, 1999CrossRefGoogle ScholarPubMed
Motzer, RJ, Nichols, CJ, Margolin, KA et al. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25:247–56, 2007CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×